{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:27:34Z","timestamp":1788269254128,"version":"build-2803163510"},"reference-count":78,"publisher":"e-Century Publishing Corporation","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/ehvj7118","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:31:29Z","timestamp":1751257889000},"page":"2657-2681","source":"Crossref","is-referenced-by-count":3,"title":["Artemisinin derivatives maintain fibroblast normalization by acting on tumor-stroma interactions in oral tongue squamous cell carcinoma"],"prefix":"10.62347","volume":"15","author":[{"given":"Weixing","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"Mody","year":"2021","unstructured":"Mody MD, Rocco JW, Yom SS, Haddad RI and Saba NF. Head and neck cancer. Lancet 2021; 398: 2289-2299.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med 2020; 382: 60-72.","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","article-title":"Targeting the tumor microenvironment: from understanding pathways to effective clinical trials","volume":"73","author":"Fang","year":"2013","unstructured":"Fang H and Declerck YA. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res 2013; 73: 4965-4977.","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","unstructured":"Roma-Rodrigues C, Mendes R, Baptista PV and Fernandes AR. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci 2019; 20: 840.","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, Zhang Q, Lin D, Ge S, Bai M, Wang X, Zhang L, Li H, Yang Y, Ji Z, Wang H, Ying G and Ba Y. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer 2020; 19: 43.","journal-title":"Mol Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fonc.2015.00063","article-title":"Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer","volume":"5","author":"Tommelein","year":"2015","unstructured":"Tommelein J, Verset L, Boterberg T, Demetter P, Bracke M and De Wever O. Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer. Front Oncol 2015; 5: 63.","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Dong L, Sun Q, Song F, Song X, Lu C, Li Y and Song X. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Heliyon 2023; 9: e14003.","DOI":"10.1016\/j.heliyon.2023.e14003"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","article-title":"In search of definitions: cancer-associated fibroblasts and their markers","volume":"146","author":"Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S and Letellier E. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer 2020; 146: 895-905.","journal-title":"Int J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Foster DS, Januszyk M, Delitto D, Yost KE, Griffin M, Guo J, Guardino N, Delitto AE, Chinta M, Burcham AR, Nguyen AT, Bauer-Rowe KE, Titan AL, Salhotra A, Jones RE, da Silva O, Lindsay HG, Berry CE, Chen K, Henn D, Mascharak S, Talbott HE, Kim A, Nosrati F, Sivaraj D, Ransom RC, Matthews M, Khan A, Wagh D, Coller J, Gurtner GC, Wan DC, Wapnir IL, Chang HY, Norton JA and Longaker MT. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell 2022; 40: 1392-1406, e7.","DOI":"10.1016\/j.ccell.2022.09.015"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"12674","DOI":"10.18632\/aging.205205","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC","volume":"15","author":"Wu","year":"2023","unstructured":"Wu X, Lu W, Zhang W, Zhang D, Mei H, Zhang M, Cui Y and Zhuo Z. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC. Aging (Albany NY) 2023; 15: 12674-12697.","journal-title":"Aging (Albany NY)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/stem.1251","article-title":"Inhibition of TGF-&#x3B2;\/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects","volume":"30","author":"Shangguan","year":"2012","unstructured":"Shangguan L, Ti X, Krause U, Hai B, Zhao Y, Yang Z and Liu F. Inhibition of TGF-&#x3B2;\/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells 2012; 30: 2810-2819.","journal-title":"Stem Cells"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s10120-021-01259-5","article-title":"Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer","volume":"25","author":"Zhang","year":"2022","unstructured":"Zhang T, Li X, He Y, Wang Y, Shen J, Wang S, You Q, Zhai J and Shen L. Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer. Gastric Cancer 2022; 25: 346-359.","journal-title":"Gastric Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","article-title":"The PDGF family: four gene products form five dimeric isoforms","volume":"15","author":"Fredriksson","year":"2004","unstructured":"Fredriksson L, Li H and Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 2004; 15: 197-204.","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/107327480701400312","article-title":"Spectrum of activity and mechanism of action of VEGF\/PDGF inhibitors","volume":"14","author":"Homsi","year":"2007","unstructured":"Homsi J and Daud AI. Spectrum of activity and mechanism of action of VEGF\/PDGF inhibitors. Cancer Control 2007; 14: 285-294.","journal-title":"Cancer Control"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/s41598-024-54801-7","article-title":"PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT\/MAPK signaling","volume":"14","author":"Xiu-Ying","year":"2024","unstructured":"Xiu-Ying H, Yue-Xiang Z, Hui-Si Y, Hong-Zhou Y, Qing-Jie X and Ting-Hua W. PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT\/MAPK signaling. Sci Rep 2024; 14: 4191.","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.lfs.2016.03.010","article-title":"dl-3-n-butylphthalide suppresses PDGF-BB-stimulated vascular smooth muscle cells proliferation via induction of autophagy","volume":"151","author":"Hu","year":"2016","unstructured":"Hu H, Liu B, Zuo Y, Liu D, Xie R and Cui W. dl-3-n-butylphthalide suppresses PDGF-BB-stimulated vascular smooth muscle cells proliferation via induction of autophagy. Life Sci 2016; 151: 182-188.","journal-title":"Life Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41586-019-1406-x","article-title":"Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy","volume":"572","author":"Lee","year":"2019","unstructured":"Lee J, Termglinchan V, Diecke S, Itzhaki I, Lam CK, Garg P, Lau E, Greenhaw M, Seeger T, Wu H, Zhang JZ, Chen X, Gil IP, Ameen M, Sallam K, Rhee JW, Churko JM, Chaudhary R, Chour T, Wang PJ, Snyder MP, Chang HY, Karakikes I and Wu JC. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature 2019; 572: 335-340.","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/joim.12690","article-title":"Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis","volume":"283","author":"CH","year":"2018","unstructured":"Heldin CH, Lennartsson J and Westermark B. Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis. J Intern Med 2018; 283: 16-44.","journal-title":"J Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","unstructured":"Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M and Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol 2019; 16: 282-295.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-a gift from traditional Chinese medicine to the world (nobel lecture)","volume":"55","author":"Tu","year":"2016","unstructured":"Tu Y. Artemisinin-a gift from traditional Chinese medicine to the world (nobel lecture). Angew Chem Int Ed Engl 2016; 55: 10210-10226.","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis","volume":"27","author":"Chen","year":"2020","unstructured":"Chen GQ, Benthani FA, Wu J, Liang D, Bian ZX and Jiang X. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ 2020; 27: 242-254.","journal-title":"Cell Death Differ"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Slezakova S and Ruda-Kucerova J. Anticancer activity of artemisinin and its derivatives. Anticancer Res 2017; 37: 5995-6003.","DOI":"10.21873\/anticanres.12046"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1128\/AAC.00262-15","article-title":"Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation","volume":"59","author":"Roy","year":"2015","unstructured":"Roy S, He R, Kapoor A, Forman M, Mazzone JR, Posner GH and Arav-Boger R. Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation. Antimicrob Agents Chemother 2015; 59: 3870-3879.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"789336","DOI":"10.3389\/fonc.2021.789336","article-title":"Dihydroartemisinin-transferrin adducts enhance TRAIL-induced apoptosisin triple-negative breast cancer in a P53-independent and ROS-dependent manner","volume":"11","author":"Zhou","year":"2022","unstructured":"Zhou X, Soto-Gamez A, Nijdam F, Setroikromo R and Quax WJ. Dihydroartemisinin-transferrin adducts enhance TRAIL-induced apoptosisin triple-negative breast cancer in a P53-independent and ROS-dependent manner. Front Oncol 2022; 11: 789336.","journal-title":"Front Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/j.ijbiomac.2020.08.198","article-title":"Artesunate, as a HSP70 ATPase activity inhibitor, induces apoptosis in breast cancer cells","volume":"164","author":"Pirali","year":"2020","unstructured":"Pirali M, Taheri M, Zarei S, Majidi M and Ghafouri H. Artesunate, as a HSP70 ATPase activity inhibitor, induces apoptosis in breast cancer cells. Int J Biol Macromol 2020; 164: 3369-3375.","journal-title":"Int J Biol Macromol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s10637-011-9676-7","article-title":"The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis","volume":"30","author":"Cabello","year":"2012","unstructured":"Cabello CM, Lamore SD, Bair WB 3rd, Qiao S, Azimian S, Lesson JL and Wondrak GT. The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Invest New Drugs 2012; 30: 1289-1301.","journal-title":"Invest New Drugs"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.2147\/OTT.S248492","article-title":"Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2\/SLC7A11 axis","volume":"13","author":"Yuan","year":"2020","unstructured":"Yuan B, Liao F, Shi ZZ, Ren Y, Deng XL, Yang TT, Li DY, Li RF, Pu DD, Wang YJ, Tan Y, Yang Z and Zhang YH. Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2\/SLC7A11 axis. Onco Targets Ther 2020; 13: 10829-10840.","journal-title":"Onco Targets Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","unstructured":"Roh JL, Kim EH, Jang H and Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol 2017; 11: 254-262.","journal-title":"Redox Biol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.intimp.2021.108427","article-title":"Dihydroartemisinin inhibits lewis lung carcinoma progression by inducing macrophages M1 polarization via AKT\/mTOR pathway","volume":"103","author":"Xiao","year":"2022","unstructured":"Xiao X, Li Y, Wang Y, Zhang Y, Chen J, Liu W, Tang J, Yue F and Yang J. Dihydroartemisinin inhibits lewis lung carcinoma progression by inducing macrophages M1 polarization via AKT\/mTOR pathway. Int Immunopharmacol 2022; 103: 108427.","journal-title":"Int Immunopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jdermsci.2020.08.001","article-title":"Dihydroartemisinin inhibits melanoma by regulating CTL\/treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner","volume":"99","author":"Yu","year":"2020","unstructured":"Yu R, Jin L, Li F, Fujimoto M, Wei Q, Lin Z, Ren X, Jin Q, Li H, Meng F and Jin G. Dihydroartemisinin inhibits melanoma by regulating CTL\/treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner. J Dermatol Sci 2020; 99: 193-202.","journal-title":"J Dermatol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s11033-021-07079-1","article-title":"Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation","volume":"49","author":"Wang","year":"2022","unstructured":"Wang CZ, Wan C, Luo Y, Zhang CF, Zhang QH, Chen L, Liu Z, Wang DH, Lager M, Li CH, Jiang TL, Hou L and Yuan CS. Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation. Mol Biol Rep 2022; 49: 2695-2709.","journal-title":"Mol Biol Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/ijms22020608","article-title":"Artesunate switches monocytes to an inflammatory phenotype with the ability to kill leukemic cells","volume":"22","author":"RI","year":"2021","unstructured":"Mancuso RI, Olalla Saad ST and Azambuja JH. Artesunate switches monocytes to an inflammatory phenotype with the ability to kill leukemic cells. Int J Mol Sci 2021; 22: 608.","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"108266","DOI":"10.1016\/j.jnutbio.2019.108266","article-title":"Epigallocatechin-3-gallate prevents TGF-&#x3B2;1-induced epithelial-mesenchymal transition and fibrotic changes of renal cells via GSK-3&#x3B2;\/&#x3B2;-catenin\/Snail1 and Nrf2 pathways","volume":"76","author":"Kanlaya","year":"2020","unstructured":"Kanlaya R, Peerapen P, Nilnumkhum A, Plumworasawat S, Sueksakit K and Thongboonkerd V. Epigallocatechin-3-gallate prevents TGF-&#x3B2;1-induced epithelial-mesenchymal transition and fibrotic changes of renal cells via GSK-3&#x3B2;\/&#x3B2;-catenin\/Snail1 and Nrf2 pathways. J Nutr Biochem 2020; 76: 108266.","journal-title":"J Nutr Biochem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111870","DOI":"10.1016\/j.biopha.2021.111870","article-title":"Caffeine prevents oxalate-induced epithelial-mesenchymal transition of renal tubular cells by its anti-oxidative property through activation of Nrf2 signaling and suppression of Snail1 transcription factor","volume":"141","author":"Kanlaya","year":"2021","unstructured":"Kanlaya R, Subkod C, Nanthawuttiphan S and Thongboonkerd V. Caffeine prevents oxalate-induced epithelial-mesenchymal transition of renal tubular cells by its anti-oxidative property through activation of Nrf2 signaling and suppression of Snail1 transcription factor. Biomed Pharmacother 2021; 141: 111870.","journal-title":"Biomed Pharmacother"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.30802\/AALAS-JAALAS-23-000014","article-title":"Isoflurane and pentobarbital anesthesia for pulmonary studies requiring prolonged mechanical ventilation in mice","volume":"63","author":"Nemzek","year":"2024","unstructured":"Nemzek JA, Hakenjos JM, Hoenerhoff MJ and Fry CD. Isoflurane and pentobarbital anesthesia for pulmonary studies requiring prolonged mechanical ventilation in mice. J Am Assoc Lab Anim Sci 2024; 63: 41-48.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","article-title":"AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases","volume":"634","author":"Li","year":"2024","unstructured":"Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, Huang H, Lu H, Song H, Yang B, Ru H, Lin S and Zhang L. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature 2024; 634: 1229-1237.","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/1471-2407-14-352","article-title":"A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer","volume":"14","author":"P&#xE9","year":"2014","unstructured":"P&#xE9;rtega-Gomes N, Vizca&#xED;no JR, Attig J, Jurmeister S, Lopes C and Baltazar F. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer. BMC Cancer 2014; 14: 352.","journal-title":"BMC Cancer"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jcp.25398","article-title":"Modulation of mammary stromal cell lactate dynamics by ambient glucose and epithelial factors","volume":"232","author":"Tobar","year":"2017","unstructured":"Tobar N, Porras O, Smith PC, Barros LF and Mart&#xED;nez J. Modulation of mammary stromal cell lactate dynamics by ambient glucose and epithelial factors. J Cell Physiol 2017; 232: 136-144.","journal-title":"J Cell Physiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/21655979.2021.2012951","article-title":"Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter","volume":"13","author":"Zheng","year":"2022","unstructured":"Zheng S, Wu R, Deng Y and Zhang Q. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter. Bioengineered 2022; 13: 227-241.","journal-title":"Bioengineered"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"45665","DOI":"10.1038\/srep45665","article-title":"A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities","volume":"7","author":"Sun","year":"2017","unstructured":"Sun C, Cao Y, Zhu P and Zhou B. A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities. Sci Rep 2017; 7: 45665.","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, Hartman J, Religa P, Morikawa H, Ishii Y, Sasahara M, Larsson O, Cossu G, Cao R, Lim S and Cao Y. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci U S A 2016; 113: E5618-5627.","DOI":"10.1073\/pnas.1608384113"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"12630","DOI":"10.1038\/ncomms12630","article-title":"ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion","volume":"7","author":"Chronopoulos","year":"2016","unstructured":"Chronopoulos A, Robinson B, Sarper M, Cortes E, Auernheimer V, Lachowski D, Attwood S, Garc&#xED;a R, Ghassemi S, Fabry B and Del R&#xED;o Hern&#xE1;ndez A. ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion. Nat Commun 2016; 7: 12630.","journal-title":"Nat Commun"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.1073\/pnas.2000648117","article-title":"Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways","volume":"117","author":"Zervantonakis","year":"2020","unstructured":"Zervantonakis IK, Poskus MD, Scott AL, Selfors LM, Lin JR, Dillon DA, Pathania S, Sorger PK, Mills GB and Brugge JS. Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proc Natl Acad Sci U S A 2020; 117: 16500-16508.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","unstructured":"Mizutani Y, Kobayashi H, Iida T, Asai N, Masamune A, Hara A, Esaki N, Ushida K, Mii S, Shiraki Y, Ando K, Weng L, Ishihara S, Ponik SM, Conklin MW, Haga H, Nagasaka A, Miyata T, Matsuyama M, Kobayashi T, Fujii T, Yamada S, Yamaguchi J, Wang T, Woods SL, Worthley D, Shimamura T, Fujishiro M, Hirooka Y, Enomoto A and Takahashi M. Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis. Cancer Res 2019; 79: 5367-5381.","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-020-1542-z","article-title":"YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression","volume":"39","author":"Shen","year":"2020","unstructured":"Shen T, Li Y, Zhu S, Yu J, Zhang B, Chen X, Zhang Z, Ma Y, Niu Y and Shang Z. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression. J Exp Clin Cancer Res 2020; 39: 36.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1158\/0008-5472.CAN-13-2275","article-title":"A systems biology approach identifies effective tumor-stroma common targets for oral squamous cell carcinoma","volume":"74","author":"Meng","year":"2014","unstructured":"Meng W, Wu Y, He X, Liu C, Gao Q, Ge L, Wu L, Liu Y, Guo Y, Li X, Liu Y, Chen S, Kong X, Liang Z and Zhou H. A systems biology approach identifies effective tumor-stroma common targets for oral squamous cell carcinoma. Cancer Res 2014; 74: 2306-2315.","journal-title":"Cancer Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"17188","DOI":"10.1073\/pnas.1419554111","article-title":"Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent","volume":"111","author":"Alkasalias","year":"2014","unstructured":"Alkasalias T, Flaberg E, Kashuba V, Alexeyenko A, Pavlova T, Savchenko A, Szekely L, Klein G and Guven H. Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent. Proc Natl Acad Sci U S A 2014; 111: 17188-17193.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12967-020-02376-y","article-title":"Antifibrotic therapy to normalize the tumor microenvironment","volume":"18","author":"Hauge","year":"2020","unstructured":"Hauge A and Rofstad EK. Antifibrotic therapy to normalize the tumor microenvironment. J Transl Med 2020; 18: 207.","journal-title":"J Transl Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-019-0782-x","article-title":"Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma","volume":"12","author":"Yin","year":"2019","unstructured":"Yin Z, Dong C, Jiang K, Xu Z, Li R, Guo K, Shao S and Wang L. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma. J Hematol Oncol 2019; 12: 101.","journal-title":"J Hematol Oncol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/14728222.2020.1751819","article-title":"Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets","volume":"24","author":"Lappano","year":"2020","unstructured":"Lappano R, Rigiracciolo DC, Belfiore A, Maggiolini M and De Francesco EM. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets. Expert Opin Ther Targets 2020; 24: 559-572.","journal-title":"Expert Opin Ther Targets"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.06.003","article-title":"Nanoformulations for combination or cascade anticancer therapy","volume":"115","author":"Miao","year":"2017","unstructured":"Miao L, Guo S, Lin CM, Liu Q and Huang L. Nanoformulations for combination or cascade anticancer therapy. Adv Drug Deliv Rev 2017; 115: 3-22.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.intimp.2016.03.011","article-title":"Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-&#x3B2;R\/ERK signaling pathway","volume":"34","author":"Chen","year":"2016","unstructured":"Chen Q, Chen L, Kong D, Shao J, Wu L and Zheng S. Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-&#x3B2;R\/ERK signaling pathway. Int Immunopharmacol 2016; 34: 250-258.","journal-title":"Int Immunopharmacol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"NC","year":"2020","unstructured":"Henderson NC, Rieder F and Wynn TA. Fibrosis: from mechanisms to medicines. Nature 2020; 587: 555-566.","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11655-019-3207-3","article-title":"Research progress on artemisinin and its derivatives against hematological malignancies","volume":"26","author":"Li","year":"2020","unstructured":"Li Y, Shan NN and Sui XH. Research progress on artemisinin and its derivatives against hematological malignancies. Chin J Integr Med 2020; 26: 947-955.","journal-title":"Chin J Integr Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2007017","DOI":"10.1002\/adfm.202007017","article-title":"FAP-targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts","volume":"31","author":"Zhou","year":"2021","unstructured":"Zhou S, Zhen Z, Paschall AV, Xue L, Yang X, Bebin-Blackwell AG, Cao Z, Zhang W, Wang M, Teng Y, Zhou G, Li Z, Avci FY, Tang W and Xie J. FAP-targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts. Adv Funct Mater 2021; 31: 2007017.","journal-title":"Adv Funct Mater"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/hep.23285","article-title":"Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma","volume":"51","author":"Mazzocca","year":"2010","unstructured":"Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S and Giannelli G. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 2010; 51: 523-534.","journal-title":"Hepatology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/cancers10090334","article-title":"Factors secreted by cancer-associated fibroblasts that sustain cancer stem properties in head and neck squamous carcinoma cells as potential therapeutic targets","volume":"10","author":"&#xC1","year":"2018","unstructured":"&#xC1;lvarez-Teijeiro S, Garc&#xED;a-Incl&#xE1;n C, Villaronga M&#xC1;, Casado P, Hermida-Prado F, Granda-D&#xED;az R, Rodrigo JP, Calvo F, Del-R&#xED;o-Ibisate N, Gandarillas A, Mor&#xED;s F, Hermsen M, Cutillas P and Garc&#xED;a-Pedrero JM. Factors secreted by cancer-associated fibroblasts that sustain cancer stem properties in head and neck squamous carcinoma cells as potential therapeutic targets. Cancers (Basel) 2018; 10: 334.","journal-title":"Cancers (Basel)"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Nahas G, Bliss SA, Sinha G, Ganta T, Greco SJ and Rameshwar P. Is reduction of tumor burden sufficient for the 21st century? Cancer Lett 2015; 356: 149-155.","DOI":"10.1016\/j.canlet.2014.03.002"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Hung Truong N, Hung Nguyen P, Nghi Do H, Ha Nguyen X, Loc Vu T, Hai Pham T, Trang Luu H, Cuong Nguyen M and Luu VC. Synthesis and cytotoxic activities of novel ether conjugates of dihydroartemisinin and zerumbone: evidenced by integrating network pharmacology and in vitro assay. Chem Biodivers 2025; 22: e202401571.","DOI":"10.1002\/cbdv.202401571"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1218467","DOI":"10.3389\/fphar.2023.1218467","article-title":"Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of burkitt&#x2019;s lymphoma cells by inhibiting AKT and ERK","volume":"14","author":"Yuan-Ce","year":"2023","unstructured":"Yuan-Ce L, Qi Z, Hong-Yang Z, Yan-Wen W, Yu-Mei S, Bi-Juan Y and Jun-Lin Y. Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of burkitt&#x2019;s lymphoma cells by inhibiting AKT and ERK. Front Pharmacol 2023; 14: 1218467.","journal-title":"Front Pharmacol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"155962","DOI":"10.1016\/j.phymed.2024.155962","article-title":"Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2\/FGFR1 signaling pathway","volume":"134","author":"Wang","year":"2024","unstructured":"Wang H, Ding Q, Zhou H, Huang C, Liu G, Zhao X, Cheng Z and You X. Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2\/FGFR1 signaling pathway. Phytomedicine 2024; 134: 155962.","journal-title":"Phytomedicine"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","article-title":"Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells","volume":"148","author":"Song","year":"2022","unstructured":"Song Q, Peng S, Che F and Zhu X. Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells. J Pharmacol Sci 2022; 148: 300-306.","journal-title":"J Pharmacol Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1007\/s00210-024-03123-6","article-title":"Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment","volume":"397","author":"Guo","year":"2024","unstructured":"Guo W, Liu Y, Chen B and Fan L. Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment. Naunyn Schmiedebergs Arch Pharmacol 2024; 397: 7711-7724.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3892\/or.2021.8191","article-title":"Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response&#x2011;induced upregulation of CHAC1 expression","volume":"46","author":"Wang","year":"2021","unstructured":"Wang Z, Li M, Liu Y, Qiao Z, Bai T, Yang L and Liu B. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response&#x2011;induced upregulation of CHAC1 expression. Oncol Rep 2021; 46: 240.","journal-title":"Oncol Rep"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Liu Y, Jiang JJ, Du SY, Mu LS, Fan JJ, Hu JC, Ye Y, Ding M, Zhou WY, Yu QH, Xia YF, Xu HY, Shi YJ, Qian SW, Tang Y, Li W, Dang YJ, Dong X, Li XY, Xu CJ and Tang QQ. Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction. Science 2024; 384: eadk5382.","DOI":"10.1126\/science.adk5382"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14218\/JCTH.2023.00162","article-title":"Artesunate induces ferroptosis in hepatic stellate cells and alleviates liver fibrosis via the ROCK1\/ATF3 axis","volume":"12","author":"Wang","year":"2024","unstructured":"Wang Y, Li Y, Qiu Y, Shen M, Wang L, Shao J, Zhang F, Xu X, Zhang Z, Guo M and Zheng S. Artesunate induces ferroptosis in hepatic stellate cells and alleviates liver fibrosis via the ROCK1\/ATF3 axis. J Clin Transl Hepatol 2024; 12: 36-51.","journal-title":"J Clin Transl Hepatol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1145188","DOI":"10.3389\/fphar.2023.1145188","article-title":"Artesunate inhibits airway remodeling in asthma via the MAPK signaling pathway","volume":"14","author":"Zhang","year":"2023","unstructured":"Zhang M, Lin J, Zhang J, Zhao R, Wan J and Nong Y. Artesunate inhibits airway remodeling in asthma via the MAPK signaling pathway. Front Pharmacol 2023; 14: 1145188.","journal-title":"Front Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/cid\/ciab133","article-title":"Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy, and safety in 1391 patients","volume":"73","author":"Roussel","year":"2021","unstructured":"Roussel C, Ndour PA, Kendjo E, Larr&#xE9;ch&#xE9; S, Taieb A, Henry B, Lebrun-Vignes B, Chambrion C, Argy N, Houz&#xE9; S, Mouri O, Courtin D, Angoulvant A, Delacour H, Gay F, Siriez JY, Danis M, Bruneel F, Bouchaud O, Caumes E, Piarroux R, Thellier M, Jaur&#xE9;guiberry S and Buffet P; FRench Artesunate Working Group. Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy, and safety in 1391 patients. Clin Infect Dis 2021; 73: 1795-1804.","journal-title":"Clin Infect Dis"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00280-016-2960-7","article-title":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study","volume":"77","author":"K&#xF6","year":"2016","unstructured":"K&#xF6;nig M, von Hagens C, Hoth S, Baumann I, Walter-Sack I, Edler L and Sertel S. Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study. Cancer Chemother Pharmacol 2016; 77: 413-427.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1158\/1078-0432.CCR-20-2833","article-title":"Cervical cancer immunotherapy: facts and hopes","volume":"27","author":"Ferrall","year":"2021","unstructured":"Ferrall L, Lin KY, Roden RBS, Hung CF and Wu TC. Cervical cancer immunotherapy: facts and hopes. Clin Cancer Res 2021; 27: 4953-4973.","journal-title":"Clin Cancer Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","article-title":"Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated plasmodium falciparum malaria: a randomised non-inferiority trial","volume":"375","author":"AK","year":"2010","unstructured":"Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS and Fleckenstein L; Pyronaridine-artesunate Study Team. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010; 375: 1457-1467.","journal-title":"Lancet"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1007\/s11033-020-05669-z","article-title":"Artemisinin and its derivatives: a promising cancer therapy","volume":"47","author":"Kiani","year":"2020","unstructured":"Kiani BH, Kayani WK, Khayam AU, Dilshad E, Ismail H and Mirza B. Artemisinin and its derivatives: a promising cancer therapy. Mol Biol Rep 2020; 47: 6321-6336.","journal-title":"Mol Biol Rep"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1056903","DOI":"10.3389\/fonc.2023.1056903","article-title":"The BAP31\/miR-181a-5p\/RECK axis promotes angiogenesis in colorectal cancer via fibroblast activation","volume":"13","author":"Zhang","year":"2023","unstructured":"Zhang Q, Wang C, Li R, Liu J, Wang J, Wang T and Wang B. The BAP31\/miR-181a-5p\/RECK axis promotes angiogenesis in colorectal cancer via fibroblast activation. Front Oncol 2023; 13: 1056903.","journal-title":"Front Oncol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","unstructured":"Lakins MA, Ghorani E, Munir H, Martins CP and Shields JD. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T cells to protect tumour cells. Nat Commun 2018; 9: 948","journal-title":"Nat Commun"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12943-019-1101-4","article-title":"Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts","volume":"18","author":"Kong","year":"2019","unstructured":"Kong J, Tian H, Zhang F, Zhang Z, Li J, Liu X, Li X, Liu J, Li X, Jin D, Yang X, Sun B, Guo T, Luo Y, Lu Y, Lin B and Liu T. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts. Mol Cancer 2019; 18: 175.","journal-title":"Mol Cancer"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41388-023-02884-3","article-title":"DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression","volume":"43","author":"Akinjiyan","year":"2024","unstructured":"Akinjiyan FA, Ibitoye Z, Zhao P, Shriver LP, Patti GJ, Longmore GD and Fuh KC. DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression. Oncogene 2024; 43: 189-201.","journal-title":"Oncogene"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1038\/s41598-019-45842-4","article-title":"An optimised tissue disaggregation and data processing pipeline for characterising fibroblast phenotypes using single-cell RNA sequencing","volume":"9","author":"Waise","year":"2019","unstructured":"Waise S, Parker R, Rose-Zerilli MJJ, Layfield DM, Wood O, West J, Ottensmeier CH, Thomas GJ and Hanley CJ. An optimised tissue disaggregation and data processing pipeline for characterising fibroblast phenotypes using single-cell RNA sequencing. Sci Rep 2019; 9: 9580.","journal-title":"Sci Rep"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/6\/ajcr0162589.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:21Z","timestamp":1766023041000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/6\/ajcr0162589.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":78,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ehvj7118","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}